Here are 19 key notes on orthopedic and spine device companies over the past week.
Alphatec Holdings, the parent company of Alphatec Spine, reported revenue was down 12.3 percent in the second quarter of this year.
Blue Belt Technologies and Acibadem Healthcare Group, a healthcare services provider in Turkey, partnered to create an orthopedic surgical robotics program.
ConforMIS released results from six clinical studies on their patient-specific implants for total knee replacement.
A patient is filing a lawsuit against DePuy Orthopedics and other subsidiaries of Johnson & Johnson for an alleged hip replacement product failure.
Greatbatch filed a Form 10 registration statement with the U.S. Securities and Exchange Commission for a spin-off of its neuromodulation subsidiary, QiG Group.
Integra Lifesciences stock was downgraded by Zacks from a "hold" rating to a "sell" rating.
InVivo Therapeutics reported $10.4 million net loss in the second quarter of 2015.
InVivo Therapeutics promoted two members of its management team — Christopher McNulty was named senior vice president of business development and investor relations and Alex Aimetti, PhD, was appointed senior director of medical education and scientific support.
Piper Jaffray restated K2M stock's had its "buy" rating.
K2M reported 18.7 percent revenue increase in the second quarter of 2015.
LDR reported total revenue of $41.5 million in the second quarter of 2015.
The first procedure using LinkSPINE's FacetLINK MINI was performed in the United States at HCA Reston (Va.) Hospital Center.
Medovex entered into an international distribution agreement with Aureus Medical.
Medtronic commenced exchange offers for certain senior notes.
Orthofix reported flat net sales of $101 million for the second quarter of 2015.
St. Jude Medical appointed President and CEO of Zimmer Biomet David Dvorak to its board of directors.
Tyber Medical will open a new site in Northampton County, Pa.
Wright Medical Group reported that second quarter net sales increased 11 percent to $80.4 million in the second quarter of 2015.
Zimmer lost $9.2 million after a Los Angeles jury ruled in favor of a man who claimed the Durom Cup caused him permanent injuries.